Ieq Capital LLC acquired a new stake in Grail, Inc. (NASDAQ:GRAL - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 19,874 shares of the company's stock, valued at approximately $355,000. Ieq Capital LLC owned approximately 0.06% of Grail at the end of the most recent reporting period.
Several other large investors have also made changes to their positions in the business. abrdn plc acquired a new position in shares of Grail during the 4th quarter worth about $3,768,000. Douglas Lane & Associates LLC acquired a new position in shares of Grail during the fourth quarter valued at approximately $3,034,000. Slow Capital Inc. purchased a new position in shares of Grail in the fourth quarter valued at approximately $2,379,000. 180 Wealth Advisors LLC purchased a new position in shares of Grail in the fourth quarter valued at approximately $1,681,000. Finally, Moloney Securities Asset Management LLC acquired a new stake in shares of Grail in the fourth quarter worth approximately $559,000.
Analyst Ratings Changes
A number of equities research analysts have recently commented on GRAL shares. Wolfe Research began coverage on shares of Grail in a research report on Friday, November 15th. They issued a "peer perform" rating for the company. Morgan Stanley began coverage on Grail in a research note on Wednesday, November 27th. They issued an "equal weight" rating and a $16.00 price target on the stock.
Check Out Our Latest Research Report on Grail
Grail Stock Performance
Grail stock traded down $2.23 during midday trading on Monday, reaching $36.33. 1,006,860 shares of the stock traded hands, compared to its average volume of 1,195,387. The company has a 50-day simple moving average of $28.90 and a two-hundred day simple moving average of $20.16. Grail, Inc. has a 12-month low of $12.33 and a 12-month high of $63.99.
Grail (NASDAQ:GRAL - Get Free Report) last posted its quarterly earnings data on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, beating the consensus estimate of ($4.41) by $2.55. The business had revenue of $38.25 million during the quarter, compared to analysts' expectations of $35.33 million. As a group, sell-side analysts forecast that Grail, Inc. will post -15.15 earnings per share for the current year.
About Grail
(
Free Report)
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
See Also
Before you consider Grail, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.
While Grail currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
